chr13-48233448-C-T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_021999.5(ITM2B):c.88C>T(p.Pro30Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000102 in 1,536,996 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_021999.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ITM2B | NM_021999.5 | c.88C>T | p.Pro30Ser | missense_variant | 1/6 | ENST00000647800.2 | NP_068839.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ITM2B | ENST00000647800.2 | c.88C>T | p.Pro30Ser | missense_variant | 1/6 | NM_021999.5 | ENSP00000497221.1 |
Frequencies
GnomAD3 genomes AF: 0.000658 AC: 100AN: 151978Hom.: 2 Cov.: 31
GnomAD3 exomes AF: 0.000238 AC: 33AN: 138666Hom.: 1 AF XY: 0.000237 AC XY: 18AN XY: 76014
GnomAD4 exome AF: 0.0000412 AC: 57AN: 1384910Hom.: 1 Cov.: 30 AF XY: 0.0000321 AC XY: 22AN XY: 684662
GnomAD4 genome AF: 0.000658 AC: 100AN: 152086Hom.: 2 Cov.: 31 AF XY: 0.000941 AC XY: 70AN XY: 74352
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 27, 2023 | The c.88C>T (p.P30S) alteration is located in exon 1 (coding exon 1) of the ITM2B gene. This alteration results from a C to T substitution at nucleotide position 88, causing the proline (P) at amino acid position 30 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 16, 2024 | - - |
ITM2B-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 16, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at